Revance Therapeutics Inc RVNC:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 07/01/22 EDT
14.33UNCH (UNCH)
Volume
8,027
Close
14.33quote price arrow up+0.51 (+3.69%)
Volume
393,936
52 week range
11.27 - 33.83
Loading...
  • Open13.85
  • Day High14.38
  • Day Low13.70
  • Prev Close13.82
  • 52 Week High33.83
  • 52 Week High Date07/09/21
  • 52 Week Low11.27
  • 52 Week Low Date06/14/22

Key Stats

  • Market Cap1.043B
  • Shares Out72.77M
  • 10 Day Average Volume0.87M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change-12.19

KEY STATS

  • Open13.85
  • Day High14.38
  • Day Low13.70
  • Prev Close13.82
  • 52 Week High33.83
  • 52 Week High Date07/09/21
  • 52 Week Low11.27
  • 52 Week Low Date06/14/22
  • Market Cap1.043B
  • Shares Out72.77M
  • 10 Day Average Volume0.87M
  • Dividend-
  • Dividend Yield-
  • Beta1.01
  • YTD % Change-12.19

RATIOS/PROFITABILITY

  • EPS (TTM)-4.04
  • P/E (TTM)-3.55
  • Fwd P/E (NTM)-3.96
  • EBITDA (TTM)-245.897M
  • ROE (TTM)-203.13%
  • Revenue (TTM)89.76M
  • Gross Margin (TTM)69.82%
  • Net Margin (TTM)-305.27%
  • Debt To Equity (MRQ)1,760.85%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Revance Therapeutics Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Revance Therapeutics, Inc. is a commercial stage biotechnology company. The Company is focused on advanced aesthetic and therapeutic offerings, including neuromodulator product, DaxibotulinumtoxinA for Injection. The DaxibotulinumtoxinA for Injection combines a proprietary stabilizing peptide excipient with a purified botulinum toxin that does not contain human or animal-based components. The Company is also evaluating additional aesthetic and therapeutic indications for...
Angus Russell
Independent Chairman of the Board
Mark Foley
Chief Executive Officer, Director
Dustin Sjuts
President
Tobin Schilke
Chief Financial Officer
Address
7555 GATEWAY BLVD., 7555 Gateway Blvd.
Newark, CA
94560
United States

Top Peers

SYMBOLLASTCHG%CHG
ENTA
Enanta Pharmaceuticals Inc
49.63+2.36+4.99%
IMGN
ImmunoGen Inc
4.61+0.11+2.44%
NGM
NGM Biopharmaceuticals Inc
12.78-0.04-0.31%
MNKD
MannKind Corp
3.98+0.17+4.46%
KYMR
Kymera Therapeutics Inc
21.10+1.41+7.16%